Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of bortezomib in adults with Philadelphia chromosome–positive leukemia
2004-002977-22Phase 2Completed
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Feb 2007
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bortezomib in leukemia and chronic myelogenous leukemia (CML), sponsored by Sant'Orsola-Malpighi University Hospital. Started Feb 2007; status: completed.
02
Drugs
bortezomib
03
Conditions
leukemiachronic myelogenous leukemia (CML)
Beyond the preview
Go deeper on 2004-002977-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002977-22.